KODAK PHARMACEUTICALS Expands Portfolio and Launches U.S. Online Store

KODAK Normal Saline, 0.9% expands Kodak's portfolio into sterile reagents for laboratory and bioprocessing workflows. Manufactured and aseptically filled in the United States, the isotonic solution is fully traceable and USP-compliant where applicable. It supports Kodak's strategy to provide customers in regulated environments with consistent quality, transparent sourcing and a more reliable domestic supply.

In parallel with this product launch, Kodak is introducing a new online store for U.S. customers, enabling direct access to its growing portfolio of pharmaceutical-grade products. At pharmastore.kodak.com customers can browse Kodak's portfolio of buffers and reagents, compare specifications, access supporting documentation and place orders.

The addition of KODAK Normal Saline, 0.9% marks the next step in Kodak's phased expansion of its pharmaceutical portfolio, which includes Water for Injection and multiple PBS formulations, with additional products planned. Kodak is also progressing toward the introduction of Class II products as part of its broader strategy to expand its portfolio and support customers with reliable, domestically produced pharmaceutical solutions.

"The launch of KODAK Normal Saline, 0.9% and our new U.S. online store reflect our commitment to making essential pharmaceutical products more accessible to customers," said Jim Continenza, Executive Chairman and Chief Executive Officer, Kodak. "By combining high-quality, domestically produced solutions with a simpler way to purchase them, we are creating a stronger foundation to serve pharmaceutical, biotech, and life science organizations."

Gill Beard

Worldwide Public Relations Manager, Eastman Kodak Company

[email protected]

+44 (0) 1923 652727